BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8008198)

  • 1. Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats.
    Engber TM; Anderson JJ; Boldry RC; Papa SM; Kuo S; Chase TN
    Neuroscience; 1994 Mar; 59(2):389-99. PubMed ID: 8008198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dizocilpine maleate, MK-801, but not 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline, NBQX, prevents transneuronal degeneration of nigral neurons after neurotoxic striatal-pallidal lesion.
    DeGiorgio LA; DeGiorgio N; Volpe BT
    Neuroscience; 1999 Apr; 90(1):79-85. PubMed ID: 10188935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic levodopa treatment alters basal and dopamine agonist-stimulated cerebral glucose utilization.
    Engber TM; Susel Z; Kuo S; Chase TN
    J Neurosci; 1990 Dec; 10(12):3889-95. PubMed ID: 1980132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
    Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.
    Papa SM; Engber TM; Boldry RC; Chase TN
    Eur J Pharmacol; 1993 Mar; 232(2-3):247-53. PubMed ID: 8385618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat.
    Kaur S; Starr MS
    Neuroscience; 1997 Jan; 76(2):345-54. PubMed ID: 9015320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine.
    Zheng P; Zhang XX; Bunney BS; Shi WX
    Neuroscience; 1999; 91(2):527-35. PubMed ID: 10366010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats.
    Wachtel H; Kunow M; Löschmann PA
    Neurosci Lett; 1992 Aug; 142(2):179-82. PubMed ID: 1280793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in Parkinsonian rats.
    Marin C; Jimenez A; Bonastre M; Chase TN; Tolosa E
    Synapse; 2000 Jun; 36(4):267-74. PubMed ID: 10819904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-related effects of continuous levodopa infusion in rats with unilateral lesions of the substantia nigra.
    Trugman JM; Hubbard CA; Bennett JP
    Brain Res; 1996 Jul; 725(2):177-83. PubMed ID: 8836523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic mapping of the synergism between MK-801 and SKF 38393 in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Pontieri FE; Morelli M; Orzi F; Terenzi R; Di Chiara G
    Synapse; 1992 Dec; 12(4):255-60. PubMed ID: 1465740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia.
    Vila M; Marin C; Ruberg M; Jimenez A; Raisman-Vozari R; Agid Y; Tolosa E; Hirsch EC
    J Neurochem; 1999 Jul; 73(1):344-52. PubMed ID: 10386987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade.
    Papa SM; Boldry RC; Engber TM; Kask AM; Chase TN
    Brain Res; 1995 Dec; 701(1-2):13-8. PubMed ID: 8925275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
    Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
    Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
    Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z
    J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic continuous and intermittent L-3,4-dihydroxyphenylalanine treatments differentially affect basal ganglia function in 6-hydroxydopamine lesioned rats--an autoradiographic study using [3H]flunitrazepam.
    Gnanalingham KK; Robertson RG
    Neuroscience; 1993 Dec; 57(3):673-81. PubMed ID: 8309530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
    El Arfani A; Bentea E; Aourz N; Ampe B; De Deurwaerdère P; Van Eeckhaut A; Massie A; Sarre S; Smolders I; Michotte Y
    Neuropharmacology; 2014 Oct; 85():198-205. PubMed ID: 24863042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.